Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform
Oversubscribed round follows the world-first compact upright proton treatment at Stanford Medicine — funding a single upright platform that will span imaging and treatment across multiple radiation modalities. MIDDLETON, Wis. & LONDON — Leo Cancer Care, the medical technology company working to reinvent how patients are imaged and treated by designing systems around the body’s […]
\